Company Earnings UpdateWalgreens Boots Alliance (NYSE: WBA) 2Q19 Results: Pricing and Reimbursement Pressures Hit Earnings; Company Lowers FY19 EPS Guidance Coresight Research April 3, 2019 Executive Summary Walgreens Boots Alliance reported 2Q19 revenues of $34.5 billion, in line with the consensus estimate and up 4.6% year over year. Diluted EPS came in at $1.24, down 8.8% year over year and below the consensus estimate of $1.50. Comps for the Retail Pharmacy USA business fell 3.8%, while Retail Pharmacy International comps decreased 1.4%. For FY19, Walgreens expects flat adjusted EPS, revised down from 7–12% growth. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Canada Store Openings and Closures Tracker 2025: Store Openings Edge Past Closures as Costco, Sephora and Uniqlo ExpandCES 2026 Preview: A Guide to What Retailers Should See and DoUS CPG Sales Tracker: Homecare and Health Dominate at the Start of 2025Global Luxury—Real Estate Insights: Brands Move from Tenants to Landlords, with Innovative, Experience-Rich Flagships
